| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Anesthesiology |
| Manuscript Type |
Expert Consensus |
| Article Title |
Expert consensus of Chinese Association for the Study of Pain on the ion channel drugs for neuropathic pain
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Hong Xiao, Ke Ma, Dong Huang, Xian-Guo Liu, Tang-Hua Liu, Qing Liu, Guang-Zhao Liu, Tao Song, Wei Tao, Da-Sheng Wu, Yun-Xia Wang, Xiao-Qiu Yang, Xiao-Mei Zhang, Hui Liu and Yan-Qing Liu |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Sichuan Science and Technology Program |
2018SZ0386 |
|
| Corresponding Author |
Hui Liu, MD, PhD, Professor, Department of Algology, West China Hospital, Sichuan University, Guo Xue Xiang #37, Wuhou District, Chengdu 610041, Sichuan Province, China. 18980601547@qq.com |
| Key Words |
Ion channel drug; Neuropathic pain; Expert consensus; Guideline; Gabapentin; Carbamazepine; Oxcarbazepine; Lidocaine; Bulleyaconitine A; Pregabalin |
| Core Tip |
Ion channel drugs are the treatment of choice for neuropathic pain, however, non-adherence to these kinds of drugs makes pain relief unsatisfactory. The Chinese Association for the Study of Pain organized first-line pain management experts from across China to write an expert consensus on the guidelines of usage of ion channel class medicines. In which, we reviewed the mechanism and characteristics of sodium and calcium channel drugs, developed the recommendations for the therapeutic principles and clinical practice for Carbamazepine, Oxcarbazepine, Lidocaine, Bulleyaconitine A, Pregabalin and Gabapentin.
Ion channel drugs are the treatment of choice for neuropathic pain, however, non-adherence to these kinds of drugs makes pain relief unsatisfactory. The Chinese Association for the Study of Pain organized first-line pain management experts from across China to write an expert consensus on the guidelines of usage of ion channel class medicines. In which, we reviewed the mechanism and characteristics of sodium and calcium channel drugs, developed the recommendations for the therapeutic principles and clinical practice for Carbamazepine, Oxcarbazepine, Lidocaine, Bulleyaconitine A, Pregabalin and Gabapentin. |
| Publish Date |
2021-03-26 09:14 |
| Citation |
Xiao H, Ma K, Huang D, Liu XG, Liu TH, Liu Q, Liu GZ, Song T, Tao W, Wu DS, Wang YX, Yang XQ, Zhang XM, Liu H, Liu YQ. Expert consensus of Chinese Association for the Study of Pain on the ion channel drugs for neuropathic pain. World J Clin Cases 2021; 9(9): 2100-2109 |
| URL |
https://www.wjgnet.com/2307-8960/full/v9/i9/2100.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v9.i9.2100 |
